Export 38 results:
[ Author(Asc)] Title Type Year
Filters: First Letter Of Last Name is I  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
J. J. Iliff, Wang, M., Liao, Y., Plogg, B. A., Peng, W., Gundersen, G. A., Benveniste, H., G Vates, E., Deane, R., Goldman, S. A., Nagelhus, E. A., and Nedergaard, M., A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid β., Sci Transl Med, vol. 4, no. 147, p. 147ra111, 2012.
S. Ikeda, Mimura, M., Ikeda, M., Wada-Isoe, K., Azuma, M., Inoue, S., and Tomita, K., Economic Burden of Alzheimer's Disease Dementia in Japan., J Alzheimers Dis, vol. 81, no. 1, pp. 309-319, 2021.
M. Ihara and Saito, S., Drug Repositioning for Alzheimer's Disease: Finding Hidden Clues in Old Drugs., J Alzheimers Dis, vol. 74, no. 4, pp. 1013-1028, 2020.
M. Ihara and Washida, K., Linking Atrial Fibrillation with Alzheimer's Disease: Epidemiological, Pathological, and Mechanistic Evidence., J Alzheimers Dis, vol. 62, no. 1, pp. 61-72, 2018.
E. T. Ighodaro, Nelson, P. T., Kukull, W. A., Schmitt, F. A., Abner, E. L., Caban-Holt, A., Bardach, S. H., Hord, D. C., Glover, C. M., Jicha, G. A., Van Eldik, L. J., Byrd, A. X., and Fernander, A., Challenges and Considerations Related to Studying Dementia in Blacks/African Americans., J Alzheimers Dis, vol. 60, no. 1, pp. 1-10, 2017.
M. Igase, Ohara, M., Igase, K., Kato, T., Okada, Y., Ochi, M., Tabara, Y., Kohara, K., and Ohyagi, Y., Skin Autofluorescence Examination as a Diagnostic Tool for Mild Cognitive Impairment in Healthy People., J Alzheimers Dis, vol. 55, no. 4, pp. 1481-1487, 2017.
M. Ienca, Fabrice, J., Elger, B., Caon, M., Pappagallo, A. Scoccia, Kressig, R. W., and Wangmo, T., Intelligent Assistive Technology for Alzheimer's Disease and Other Dementias: A Systematic Review., J Alzheimers Dis, vol. 56, no. 4, pp. 1301-1340, 2017.
E. Idrizbegovic, Hederstierna, C., and Rosenhall, U., Mismatch Negativity and Ear Laterality in Alzheimer's Disease and in Mild Cognitive Impairment., J Alzheimers Dis, vol. 53, no. 4, pp. 1405-10, 2016.
A. - V. Idland, Wyller, T. Bruun, Støen, R., Eri, L. Magne, Frihagen, F., Ræder, J., Chaudhry, F. Abbas, Hansson, O., Zetterberg, H., Blennow, K., Bogdanovic, N., Brækhus, A., and Watne, L. Otto, Preclinical Amyloid-β and Axonal Degeneration Pathology in Delirium., J Alzheimers Dis, vol. 55, no. 1, pp. 371-379, 2017.
N. Faeizah Ibrahim, Yanagisawa, D., Durani, L. Wati, Hamezah, H. Shahirah, Damanhuri, H. Ahmad, Ngah, W. Zurinah Wa, Tsuji, M., Kiuchi, Y., Ono, K., and Tooyama, I., Tocotrienol-Rich Fraction Modulates Amyloid Pathology and Improves Cognitive Function in AβPP/PS1 Mice., J Alzheimers Dis, vol. 55, no. 2, pp. 597-612, 2017.
M. Ibarria, Alegret, M., Valero, S., Morera, A., Guitart, M., Cañabate, P., Moreno, M., Lara, S., Diego, S., Hernández, J., Tantinyá, N., Vera, M., Hernandez, I., Becker, J. T., Ruiz, A., Boada, M., and Tárraga, L., Beneficial Effects of an Integrated Psychostimulation Program in Patients with Alzheimer's Disease., J Alzheimers Dis, vol. 50, no. 2, pp. 559-66, 2016.
L. Iaccarino, Chiotis, K., Alongi, P., Almkvist, O., Wall, A., Cerami, C., Bettinardi, V., Gianolli, L., Nordberg, A., and Perani, D., A Cross-Validation of FDG- and Amyloid-PET Biomarkers in Mild Cognitive Impairment for the Risk Prediction to Dementia due to Alzheimer's Disease in a Clinical Setting., J Alzheimers Dis, vol. 59, no. 2, pp. 603-614, 2017.
L. Iaccarino, Marelli, S., Iannaccone, S., Magnani, G., Ferini-Strambi, L., and Perani, D., Severe Brain Metabolic Decreases Associated with REM Sleep Behavior Disorder in Dementia with Lewy Bodies., J Alzheimers Dis, vol. 52, no. 3, pp. 989-97, 2016.